
NKMAX Co., Ltd. — Investor Relations & Filings
NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]주요사항보고서(유상증자결정) | 2023-12-18 | Korean | |
| 주주명부폐쇄기간또는기준일설정 | 2023-12-15 | Korean | |
| 주권매매거래정지(무상증자) | 2023-12-06 | Korean | |
| 주요사항보고서(무상증자결정) | 2023-12-06 | Korean | |
| 주주명부폐쇄기간또는기준일설정 | 2023-12-06 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2023-11-22 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 8238416 | [기재정정]주요사항보고서(유상증자결정) | 2023-12-18 | Korean | ||
| 8239493 | 주주명부폐쇄기간또는기준일설정 | 2023-12-15 | Korean | ||
| 8245988 | 주권매매거래정지(무상증자) | 2023-12-06 | Korean | ||
| 8245987 | 주요사항보고서(무상증자결정) | 2023-12-06 | Korean | ||
| 8245982 | 주주명부폐쇄기간또는기준일설정 | 2023-12-06 | Korean | ||
| 8251451 | 주식등의대량보유상황보고서(일반) | 2023-11-22 | Korean | ||
| 8258616 | [기재정정]반기보고서 (2023.06) | 2023-11-14 | Korean | ||
| 8258519 | 분기보고서 (2023.09) | 2023-11-14 | Korean | ||
| 8272599 | 주요사항보고서(유상증자결정) | 2023-10-20 | Korean | ||
| 8272532 | 풍문또는보도에대한해명(미확정) | 2023-10-20 | Korean | ||
| 8273236 | [기재정정]단일판매ㆍ공급계약체결 | 2023-10-19 | Korean | ||
| 8274556 | 전환가액의조정 | 2023-10-16 | Korean | ||
| 8277207 | [기재정정]주권관련사채권의취득결정 | 2023-10-10 | Korean | ||
| 8277206 | [기재정정]주권관련사채권의취득결정 | 2023-10-10 | Korean | ||
| 8276582 | 투자판단관련주요경영사항(임상시험계획변경승인)(표준요법에 실패한 전이 또는 국소적으로 진행된 고형암 환자를 대상으로 SNK02 정맥 투여의 내약성,안전성 평가 및 항종양 효과 탐색을 위한 공개,용량대조,3+3 설계,용량증량,다기관,1상 임상시험 계획 변경 승인) | 2023-10-10 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
NKMAX Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17727/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17727 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17727 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17727 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17727}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NKMAX Co., Ltd. (id: 17727)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.